Search details
1.
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells.
Haematologica
; 108(2): 568-580, 2023 02 01.
Article
in English
| MEDLINE | ID: mdl-36722406
2.
Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations.
Front Cell Dev Biol
; 12: 1376554, 2024.
Article
in English
| MEDLINE | ID: mdl-38694825
3.
Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies.
Front Immunol
; 14: 1152498, 2023.
Article
in English
| MEDLINE | ID: mdl-37122702
4.
Overcoming Chimeric Antigen Receptor (CAR) Modified T-Cell Therapy Limitations in Multiple Myeloma.
Front Immunol
; 11: 1128, 2020.
Article
in English
| MEDLINE | ID: mdl-32582204
Results
1 -
4
de 4
1
Next >
>>